1365 Clifton Rd NEClinic Building B, Suite 1400Atlanta, GA 30322
Fax+1 404-778-4006
Overview of Dr. Narayan
Dr. Vikram Narayan specializes in the surgical treatment of urologic cancers.
Dr. Narayan received his MD degree from the University of Florida College of Medicine in 2013. His general surgery internship and urology residency were done at the University of Minnesota, after which he completed a fellowship in urologic oncology at the University of Texas MD Anderson Cancer in 2020. During his fellowship, Dr. Narayan completed a year of basic science research investigating novel therapeutics for urothelial cancers including intravesical gene therapy, immune-based treatment options, and the role of the urinary microbiome in bladder cancer treatment.
Dr. Narayan's current research interests concentrate on understanding the mechanisms that underlie bladder cancer treatment responses in order to improve patients' therapeutic options. He has led projects studying quality outcomes for patients being treated for urothelial cancer. Dr. Narayan additionally has an interest in methodologic research, and has published several peer-reviewed articles about the performance of clinical urologic research and the transparent reporting of randomized trials and systematic reviews.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2018 - 2020
University of MinnesotaResidency, Urology, 2014 - 2018
University of MinnesotaResidency, Surgery, 2013 - 2014
University of Florida College of MedicineClass of 2013
Certifications & Licensure
GA State Medical License 2020 - 2028
TX State Medical License 2017 - 2027
MN State Medical License 2013 - 2018
American Board of Preventive Medicine Clinical Informatics
American Board of Urology Urology
Publications & Presentations
PubMed
- Mental health disorders following nephrectomy for renal cell carcinoma: a national study.Baris Esen, Reza Lahiji, Dattatraya Patil, Susan Mumford, Kelsey R Landrum
BJU International. 2026-07-11 - Contemporary Validation of the Renal Cell Carcinoma Inflammatory Score (RISK) for Preoperative Prognostication in Non-Metastatic Renal Cell Carcinoma.Adam Braunschweig, Gabriel Ekene Agu, Reza Lahiji, Dattatraya Patil, Bariş Esen
Urology Practice. 2026-06-15 - Evaluating the Diagnostic Performance of Clear Cell Likelihood Score in Predicting Clear Cell Renal Cell Carcinoma Among Patients Younger Than 50 Years.Alexander Abdollahzadeh, Reza Lahiji, Matthew Harris, Dattatraya Patil, Ayushi Gupta
JCO Oncology Practice. 2026-06-15
Books/Book Chapters
Press Mentions
iPhones, iPads and Apple Watches Among Apple Gadgets That Greatly Aid This Georgia HospitalMay 23rd, 2025
Apple Products Transform Care at Emory HealthcareMay 22nd, 2025
Immune Cell Find Boosts Cancer Immunotherapy HopesOctober 26th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










